Tag: biosimilar
May 3, 2018
New to the Investing News Network
Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...
March 1, 2018
Biocure appoints Lichtenwald CFO, director
Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the"Company" or "Biocure") is pleased to announce that effective of today's... February 21, 2018
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
Momenta Pharmaceuticals (Nasdaq:MNTA) today reported its financial results for the fourth quarter and year ended December 31, 2017 and provided a...
February 20, 2018
BioCure Announces a Contract with Osong Hi-Tech Medical Industry Promotion Foundation
Biocure Technology Inc. (CSE: CURE) (formerly Gravis Energy Corp.) (the “Company” or “Biocure”) announces that on February 19, 2018, has...
February 15, 2018
Agios Receives FDA Priority Review for New Drug Application: How are Gene Therapy Drug Approvals Impacting Stocks?
INN is taking a look at what other companies have received FDA approval for gene therapy drugs and how the... February 14, 2018
Oncobiologics Reports First Quarter Fiscal Year 2018 Results
Oncobiologics (NASDAQ:ONS) today reported financial results and business highlights for its first fiscal quarter ended December 31, 2017. Oncobiologics had... January 31, 2018